Skip to content
Open access · CC-BY via OpenAlex

Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World

Luis E. Fernández-Garza, Silvia A. Barrera‐Barrera, Hugo Alberto Barrera-Saldaña

Pharmaceuticals · 2023 · ▲ 87 citations

Abstract

Cellular therapy has used mesenchymal stem cells (MSCs), which in cell culture are multipotent progenitors capable of producing a variety of cells limited to the mesoderm layer. There are two types of MSC sources: (1) adult MSCs, which are obtained from bone marrow, adipose tissue, peripheral blood, and dental pulp; and (2) neonatal-tissue-derived MSCs, obtained from extra-embryonic tissues such as the placenta, amnion, and umbilical cord. Until April 2023, 1120 registered clinical trials had been using MSC therapies worldwide, but there are only 12 MSC therapies that have been approved by regulatory agencies for commercialization. Nine of the twelve MSC-approved products are from Asia, with Republic of Korea being the country with the most approved therapies. In the future, MSCs will play an important role in the treatment of many diseases. However, there are many issues to deal with before their application and usage in the medical field. Some strategies have been proposed to face these problems with the hope of reaching the objective of applying these MSC therapies at optimal therapeutic levels.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ph16091334
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Fernández-Garza, L.E., Barrera‐Barrera, S.A., &amp; Barrera-Saldaña, H.A. (2023). Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World. <em>Pharmaceuticals</em>. https://doi.org/10.3390/ph16091334
Vancouver
Fernández-Garza LE, Barrera‐Barrera SA, Barrera-Saldaña HA. Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World. Pharmaceuticals. 2023. doi:10.3390/ph16091334.
BibTeX
@article{luis2023Mesenc, title = {Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World}, author = {Luis E. Fernández-Garza and Silvia A. Barrera‐Barrera and Hugo Alberto Barrera-Saldaña}, journal = {Pharmaceuticals}, year = {2023}, doi = {10.3390/ph16091334}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings